214 related articles for article (PubMed ID: 35546765)
1. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
Ray SK; Mukherjee S
Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic biomarkers in colorectal cancer: premises and prospects.
Zamani M; Hosseini SV; Mokarram P
Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
6. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
8. Value of methylation markers in colorectal cancer (Review).
Kong C; Fu T
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
[TBL] [Abstract][Full Text] [Related]
9. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
[TBL] [Abstract][Full Text] [Related]
10. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.
Yang Y; Yan X; Li X; Ma Y; Goel A
Cancer Lett; 2021 Apr; 504():67-80. PubMed ID: 33577977
[TBL] [Abstract][Full Text] [Related]
14. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
15. Epigenetic Biomarkers in Colorectal Cancer.
Verma M; Kumar V
Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
Okugawa Y; Grady WM; Goel A
Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
Cao Q; Tian Y; Deng Z; Yang F; Chen E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
[TBL] [Abstract][Full Text] [Related]
20. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
